Sudarshan Pharma Industries Ltd — Others, 14-06-2025: AGM/EGM

Sudarshan Pharma Industries has announced the results of its Extraordinary General Meeting conducted via video conferencing. All resolutions were approved with overwhelming shareholder support. Key approvals include authority to create charges and borrow up to Rs. 2500 Crores, and multiple related party transactions with its wholly-owned subsidiaries and related entities. These approvals enhance the company’s financial flexibility and formalize ongoing transactions with its group companies, supporting its operational and strategic initiatives. Voting was conducted through remote e-voting and during the meeting, with 100% votes in favor across all resolutions.